Literature DB >> 29383519

PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.

Suyun Chen1, Shaoyan Wang1, Kejun He2, Chao Ma1, Hongliang Fu1, Hui Wang3.   

Abstract

OBJECTIVES: To investigate the role of 18F-FDG PET/CT to detect bone marrow (BM) involvement in paediatric non-Hodgkin lymphoma (NHL).
METHODS: Pretreatment PET/CT scans from 93 consecutive paediatric patients with NHL were retrospectively reviewed. Patterns of BM FDG uptake and standardized uptake value of the fifth lumbar vertebra (SUVBM) were compared with bone marrow biopsy (BMB) for diagnosis of BM involvement.
RESULTS: Of 93 patients, 41 were judged to have BM involvement. Thirty-nine were identified by PET/CT, versus 23 by BMB. Sensitivity and specificity were 95 % and 98 % for PET/CT and 56 % and 100 % for BMB, respectively. None of the patients with BM FDG uptake lower than liver had positive BMB. In 45 patients presenting homogeneously increased BM uptake, positive BMB was achieved in 93 % (14/15) of patients with FDG uptake expanding to the distal portion of extremities, compared to 7 % (2/30) of those without. A multifocal pattern was observed in 25 patients and 18 had negative BMB. SUVBM differentiated BM involvement from benign BM activation with an area under the curve of 0.885 (p < 0.001).
CONCLUSIONS: PET/CT had a high level of accuracy for detecting BM involvement in paediatric NHL. BMB might be omitted in selected patients. KEY POINTS: • PET/CT allows for accurate detection of bone marrow involvement. • Patterns of bone marrow FDG uptake are highly correlated with marrow disease. • Bone marrow biopsy could be omitted in selected paediatric patients.

Entities:  

Keywords:  Biopsy; Bone marrow; Non-Hodgkin lymphoma; Paediatrics; Positron-emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29383519     DOI: 10.1007/s00330-018-5306-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.

Authors:  Emilios E Pakos; Andreas D Fotopoulos; John P A Ioannidis
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

2.  Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.

Authors:  Kanhaiyalal Agrawal; Bhagwant Rai Mittal; Deepak Bansal; Neelam Varma; Radhika Srinivasan; Amita Trehan; Kuruva Manohar; Raghava Kashyap; Anish Bhattacharya; Ram K Marwaha
Journal:  Ann Nucl Med       Date:  2012-11-11       Impact factor: 2.668

3.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

4.  [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.

Authors:  Sandra Purz; Christine Mauz-Körholz; Dieter Körholz; Dirk Hasenclever; Antje Krausse; Ina Sorge; Kathrin Ruschke; Martina Stiefel; Holger Amthauer; Otmar Schober; W Tilman Kranert; Wolfgang A Weber; Uwe Haberkorn; Patrick Hundsdörfer; Karoline Ehlert; Martina Becker; Jochen Rössler; Andreas E Kulozik; Osama Sabri; Regine Kluge
Journal:  J Clin Oncol       Date:  2011-08-08       Impact factor: 44.544

5.  Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.

Authors:  Gang Cheng; Wengen Chen; Wichana Chamroonrat; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

6.  (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.

Authors:  Michal Weiler-Sagie; Olga Bushelev; Ron Epelbaum; Eldad J Dann; Nissim Haim; Irit Avivi; Ayelet Ben-Barak; Yehudit Ben-Arie; Rachel Bar-Shalom; Ora Israel
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

7.  Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of T-lymphoblastic lymphoma patients.

Authors:  Jong Hoon Park; Kisoo Pahk; Sungeun Kim; Sang Moo Lim; Gi Jeong Cheon; Yeon Hee Park; Seung-Sook Lee; Jae Gol Choe
Journal:  Oncol Lett       Date:  2016-06-29       Impact factor: 2.967

8.  (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.

Authors:  Chaitra S Ujjani; Elizabeth M Hill; Hongkun Wang; Samer Nassif; Giuseppe Esposito; Metin Ozdemirli; Christine Cordova; Bruce D Cheson
Journal:  Br J Haematol       Date:  2016-04-20       Impact factor: 6.998

9.  Conversion of bone marrow in the humerus, sternum, and clavicle: changes with age on MR images.

Authors:  J K Zawin; D Jaramillo
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

Review 10.  Radionuclide imaging of bone marrow disorders.

Authors:  Ali Agool; Andor W J M Glaudemans; Hendrikus H Boersma; Rudi A J O Dierckx; Edo Vellenga; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

View more
  6 in total

1.  Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults.

Authors:  Ali Rashidi; Lucia Baratto; Ashok Joseph Theruvath; Elton Benjamin Greene; K Elizabeth Hawk; Rong Lu; Michael P Link; Sheri L Spunt; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2022-01-31       Impact factor: 7.034

Review 2.  Role of Radiomics-Based Baseline PET/CT Imaging in Lymphoma: Diagnosis, Prognosis, and Response Assessment.

Authors:  Han Jiang; Ang Li; Zhongyou Ji; Mei Tian; Hong Zhang
Journal:  Mol Imaging Biol       Date:  2022-01-14       Impact factor: 3.484

3.  Utility of 18F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma.

Authors:  Ankit Kumar Jitani; Shyamali Dutta; Prakas Kumar Mandal; Rajib De; Ekta Jajodia; Shuvraneel Baul; Prantar Chakrabarti; Tuphan Kanti Dolai
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

4.  The Diagnostic Value of 18F-FDG PET/CT Bone Marrow Uptake Pattern in Detecting Bone Marrow Involvement in Pediatric Neuroblastoma Patients.

Authors:  Jun Liu; Cuicui Li; Xu Yang; Xia Lu; Mingyu Zhang; Luodan Qian; Wei Wang; Ying Kan; Jigang Yang
Journal:  Contrast Media Mol Imaging       Date:  2022-01-06       Impact factor: 3.161

5.  Increase of CD3+CD7- T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin's lymphoma.

Authors:  Ziyang Huang; Binbin Chen; Yixin Ling; Yangya Pan; Songfu Jiang; Shenghui Zhang; Kang Yu; Yixiang Han
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

Review 6.  FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis.

Authors:  Zhizhuo Li; Chengxin Li; Bingrong Chen; Lijun Shi; Fuqiang Gao; Peixu Wang; Wei Sun
Journal:  J Orthop Surg Res       Date:  2021-08-09       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.